Delivery Order SPE2DB22D3501-SPE2DB24FXA42

Award Date 9/19/24
Potential Completion Date 9/20/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Carvedilol ER 40 mg capsules. The contract has a ceiling value of $18,940.52 and an ultimate completion date of September 11, 2024. AmerisourceBergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to $999,999,999, and the Department of Justice Federal Bureau of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Carvedilol ER 40 mg capsules. The contract has a ceiling value of $5,012.24 and an ultimate completion date of June 25, 2025. This award is not set-aside and represents open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,146.86, is for the delivery of Carvedilol ER 40 mg capsules. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 8, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,338.87 firm fixed price contract is for the delivery of Carvedilol ER 40 mg capsules. The contract has a performance period extending until June 10, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Carvedilol ER 40 mg capsules, with a ceiling value of $7,314.68 and a performance period through June 25, 2025. The contract is a firm fixed-price arrangement and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of Carvedilol ER 40 mg capsules. The contract has a ceiling value of $22,885.85 and an ultimate completion date of August 2, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor responsible for providing these prescription medications to support military...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply Carvedilol ER 40 mg capsules. The contract has a ceiling value of $3,288.18 and an ultimate completion date of June 4, 2025. The contract is not set aside and represents open competition. AmerisourceBergen Drug Corp is the prime contractor, and there are no major subcontractors mentioned. This delivery order is part of a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,793.06 firm fixed-price contract is for the supply of Carvedilol ER 40 mg capsules, a medication used to treat certain cardiovascular conditions. The contract has an ultimate completion date of January 24, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Carvedilol ER 40 mg capsules and has a ceiling value of $5,229.69. The contract has an ultimate completion date of January 21, 2025 and is a Firm Fixed Price Delivery Order. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,285.52, is for the delivery of Carvedilol ER 40 mg capsules. It is a firm fixed-price delivery order contract with an ultimate completion date of April 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FXA42
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $12,830.81, is for the provision of Carvedilol ER 40 mg capsules. The contract has a period of performance through September 20, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued at up to $999,999,999 and $750,000 respectively, to supply a broad range of pharmaceutical and medical products to support military treatment facilities, veterans' hospitals, and other government healthcare programs. This contract award is not associated with a set-aside program.

Generated 12/19/24, 9:26 AM